212 related articles for article (PubMed ID: 33076926)
1. Hepatitis C in Israeli prisons: status report.
Michaeli N; Litvin A; Davidovitch N
Harm Reduct J; 2020 Oct; 17(1):79. PubMed ID: 33076926
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus Elimination Program among Prison Inmates, Israel.
Eisen L; Mor Z; Madar M; Rabinovitch R; Dadon Y; Sheffer R; Kaliner E; Goldstein L
Emerg Infect Dis; 2023 Nov; 29(11):2358-2361. PubMed ID: 37877627
[TBL] [Abstract][Full Text] [Related]
3. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.
Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Boamah I; Adu-Gyamfi C; Asare I; Hesse IF; Mensah G
BMC Infect Dis; 2008 Mar; 8():33. PubMed ID: 18328097
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana.
Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Quaye IKE; Hesse IFA; Mensah G
J Med Microbiol; 2006 May; 55(Pt 5):593-597. PubMed ID: 16585647
[TBL] [Abstract][Full Text] [Related]
5. Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.
Stöver H; Meroueh F; Marco A; Keppler K; Saiz de la Hoya P; Littlewood R; Wright N; Nava F; Alam F; Walcher S; Somaini L
BMC Public Health; 2019 Jan; 19(1):30. PubMed ID: 30621658
[TBL] [Abstract][Full Text] [Related]
6. Surveillance and prevention of hepatitis C in Australian prisons.
Dolan K
Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):68-9. PubMed ID: 11833205
[TBL] [Abstract][Full Text] [Related]
7. Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.
Walker SJ; Shrestha LB; Lloyd AR; Dawson O; Sheehan Y; Sheehan J; Maduka NBC; Cabezas J; Akiyama MJ; Kronfli N;
Int J Drug Policy; 2024 Apr; 126():104386. PubMed ID: 38492433
[TBL] [Abstract][Full Text] [Related]
8. Palliative and end-of-life care in prisons: a content analysis of the literature.
Maschi T; Marmo S; Han J
Int J Prison Health; 2014; 10(3):172-97. PubMed ID: 25764177
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
[TBL] [Abstract][Full Text] [Related]
11. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J
Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715
[TBL] [Abstract][Full Text] [Related]
12. Enhancing assessment and treatment of hepatitis C in the custodial setting.
Post JJ; Arain A; Lloyd AR
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S70-4. PubMed ID: 23884069
[TBL] [Abstract][Full Text] [Related]
13. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
Rance J; Lafferty L; Treloar C;
Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison.
Okafor IM; Ugwu SO; Okoroiwu HU
BMC Gastroenterol; 2020 Oct; 20(1):360. PubMed ID: 33126856
[TBL] [Abstract][Full Text] [Related]
15. Medicaid Enrollment among Prison Inmates in a Non-expansion State: Exploring Predisposing, Enabling, and Need Factors Related to Enrollment Pre-incarceration and Post-Release.
Grodensky CA; Rosen DL; Blue CM; Miller AR; Bradley-Bull S; Powell WA; Domino ME; Golin CE; Wohl DA
J Urban Health; 2018 Aug; 95(4):454-466. PubMed ID: 29934825
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.
Crowley D; Van Hout MC; Murphy C; Kelly E; Lambert JS; Cullen W
Health Justice; 2018 Dec; 6(1):23. PubMed ID: 30569249
[TBL] [Abstract][Full Text] [Related]
18. Testing for hepatitis C virus infection in UK prisons: What actually happens?
Jack K; Thomson BJ; Irving WL
J Viral Hepat; 2019 Jun; 26(6):644-654. PubMed ID: 30702194
[TBL] [Abstract][Full Text] [Related]
19. Inmate-on-Inmate Prison Violence in Chile: The Importance of the Institutional Context and Proper Supervision.
Sanhueza GE; Pérez F; Candia J; Urquieta MA
J Interpers Violence; 2021 Dec; 36(23-24):NP13391-NP13414. PubMed ID: 32081065
[TBL] [Abstract][Full Text] [Related]
20. A legal-realist assessment of human rights, right to health and standards of healthcare in the Malawian prison system during COVID-19 state disaster measures.
Van Hout MC; Mhango V; Kaima R; Bigland C; Mariniello T
Int J Prison Health; 2022 Mar; ():. PubMed ID: 35294830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
